BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33535181)

  • 1. Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease.
    Zhou R; Qiu P; Wang H; Yang H; Yang X; Ye M; Wang F; Zhao Q
    Aging (Albany NY); 2021 Feb; 13(3):4634-4646. PubMed ID: 33535181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases.
    Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A
    Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
    Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
    Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue and serum miR-149-3p/5p in hospitalized patients with inflammatory bowel disease: Correlation with disease severity and inflammatory markers.
    Luo S; Chen XH
    Kaohsiung J Med Sci; 2024 Feb; 40(2):131-138. PubMed ID: 37997516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease.
    Thorsvik S; Damås JK; Granlund AV; Flo TH; Bergh K; Østvik AE; Sandvik AK
    J Gastroenterol Hepatol; 2017 Jan; 32(1):128-135. PubMed ID: 27640344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.
    Fasseu M; Tréton X; Guichard C; Pedruzzi E; Cazals-Hatem D; Richard C; Aparicio T; Daniel F; Soulé JC; Moreau R; Bouhnik Y; Laburthe M; Groyer A; Ogier-Denis E
    PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease.
    Kalla R; Adams AT; Ventham NT; Kennedy NA; White R; Clarke C; Ivens A; Bergemalm D; Vatn S; Lopez-Jimena B; ; Ricanek P; Vatn MH; Söderholm JD; Gomollón F; Nowak JK; Jahnsen J; Halfvarson J; McTaggart S; Ho GT; Buck A; Satsangi J
    J Crohns Colitis; 2020 Dec; 14(12):1724-1733. PubMed ID: 32598439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease.
    Shaker OG; Safa A; Khairy A; Abozeid NF
    Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-mRNA Networks Linked to Inflammation and Immune System Regulation in Inflammatory Bowel Disease.
    Síbia CF; Quaglio AEV; Oliveira ECS; Pereira JN; Ariede JR; Lapa RML; Severino FE; Reis PP; Sassaki LY; Saad-Hossne R
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.
    Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G
    Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease.
    Chen P; Li Y; Li L; Yu Q; Chao K; Zhou G; Qiu Y; Feng R; Huang S; He Y; Chen B; Chen M; Zeng Z; Zhang S
    Aliment Pharmacol Ther; 2019 Mar; 49(6):733-743. PubMed ID: 30734320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.
    James JP; Riis LB; Malham M; Høgdall E; Langholz E; Nielsen BS
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MicroRNA in inflammatory bowel disease.
    Paraskevi A; Theodoropoulos G; Papaconstantinou I; Mantzaris G; Nikiteas N; Gazouli M
    J Crohns Colitis; 2012 Oct; 6(9):900-4. PubMed ID: 22386737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Gene Expression Profiles Involved in the Inflammations Due to COVID-19 and Inflammatory Bowel Diseases and  the Investigation of Predictive Biomarkers.
    Aishwarya S; Gunasekaran K
    Biochem Genet; 2024 Feb; 62(1):311-332. PubMed ID: 37335372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated miRNA Inversely Correlates with
    Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K
    Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-199a and long noncoding-RNA ANRIL as Promising Diagnostic Biomarkers for Inflammatory Bowel Disease.
    Erfan R; Shaker OG; Khalil MAF; Mahmoud FAM; Gomaa MS; Abu-El-Azayem AK; Zaki OM; Ahmed AM; Samy A; Mohammed A
    Inflamm Bowel Dis; 2024 Jan; ():. PubMed ID: 38190238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal MicroRNAs Show Promise as Noninvasive Crohn's Disease Biomarkers.
    Wohnhaas CT; Schmid R; Rolser M; Kaaru E; Langgartner D; Rieber K; Strobel B; Eisele C; Wiech F; Jakob I; Gantner F; Herichova I; Vinisko R; Böcher WO; Visvanathan S; Shen F; Panzenbeck M; Raymond E; Reber SO; Delić D; Baum P
    Crohns Colitis 360; 2020 Jan; 2(1):otaa003. PubMed ID: 32551441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.